Roman Bohovic

431 total citations
10 papers, 335 citations indexed

About

Roman Bohovic is a scholar working on Oncology, Genetics and Biotechnology. According to data from OpenAlex, Roman Bohovic has authored 10 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Genetics and 7 papers in Biotechnology. Recurrent topics in Roman Bohovic's work include Virus-based gene therapy research (7 papers), Cancer Research and Treatments (7 papers) and Mesenchymal stem cell research (5 papers). Roman Bohovic is often cited by papers focused on Virus-based gene therapy research (7 papers), Cancer Research and Treatments (7 papers) and Mesenchymal stem cell research (5 papers). Roman Bohovic collaborates with scholars based in Slovakia. Roman Bohovic's co-authors include Lucia Kučerová, Miroslava Matúšková, Silvia Tyčiaková, Andrea Pastorakova, Veronika Altanerová, Č Altaner, Jana Jakubı́ková, Erika Durinikova, Zuzana Kozovská and Zuzana Čierna and has published in prestigious journals such as Cancer Letters, BMC Cancer and Gene Therapy.

In The Last Decade

Roman Bohovic

10 papers receiving 332 citations

Peers

Roman Bohovic
C Zischek Germany
Tarlochan Nijjar United States
Simone Haas Germany
Kirsten G. Edington United Kingdom
Roman Bohovic
Citations per year, relative to Roman Bohovic Roman Bohovic (= 1×) peers Andrea Pastorakova

Countries citing papers authored by Roman Bohovic

Since Specialization
Citations

This map shows the geographic impact of Roman Bohovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roman Bohovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roman Bohovic more than expected).

Fields of papers citing papers by Roman Bohovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roman Bohovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roman Bohovic. The network helps show where Roman Bohovic may publish in the future.

Co-authorship network of co-authors of Roman Bohovic

This figure shows the co-authorship network connecting the top 25 collaborators of Roman Bohovic. A scholar is included among the top collaborators of Roman Bohovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roman Bohovic. Roman Bohovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Durinikova, Erika, Zuzana Kozovská, Jana Plavá, et al.. (2018). ALDH1A3 upregulation and spontaneous metastasis formation is associated with acquired chemoresistance in colorectal cancer cells. BMC Cancer. 18(1). 848–848. 48 indexed citations
2.
Tyčiaková, Silvia, Miroslava Matúšková, Roman Bohovic, & Lucia Kučerová. (2017). Mesenchymal stromal cells producing TNFα lack inhibitory effect against A375 experimental lung metastases. Neoplasma. 64(2). 222–227. 7 indexed citations
3.
Bohovic, Roman, et al.. (2016). Metastatic Ovarian Cancer Can Be Efficiently Treated by Genetically Modified Mesenchymal Stromal Cells. Stem Cells and Development. 25(21). 1640–1651. 12 indexed citations
4.
Kučerová, Lucia, et al.. (2016). Tyrosine kinase inhibitor SU11274 increased tumorigenicity and enriched for melanoma-initiating cells by bioenergetic modulation. BMC Cancer. 16(1). 308–308. 7 indexed citations
5.
Matúšková, Miroslava, Zuzana Kozovská, Erika Durinikova, et al.. (2015). Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases. Journal of Experimental & Clinical Cancer Research. 34(1). 33–33. 35 indexed citations
6.
Tyčiaková, Silvia, et al.. (2015). Genetically engineered mesenchymal stromal cells producing TNFα have tumour suppressing effect on human melanoma xenograft. The Journal of Gene Medicine. 17(1-2). 54–67. 32 indexed citations
7.
Bohovic, Roman, Lucia Demková, Marina Cihova, et al.. (2015). 3D multicellular models reflect the efficiency of MSC-directed enzyme/prodrug treatment. Neoplasma. 62(4). 521–530. 7 indexed citations
8.
Kučerová, Lucia, et al.. (2014). Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC/5FC therapy in human melanoma xenograft model. Gene Therapy. 21(10). 874–887. 29 indexed citations
9.
Kučerová, Lucia, Miroslava Matúšková, K Hlubinová, et al.. (2011). Bystander cytotoxicity in human medullary thyroid carcinoma cells mediated by fusion yeast cytosine deaminase and 5-fluorocytosine. Cancer Letters. 311(1). 101–112. 19 indexed citations
10.
Kučerová, Lucia, Miroslava Matúšková, Andrea Pastorakova, et al.. (2008). Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice. The Journal of Gene Medicine. 10(10). 1071–1082. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026